CMPX icon

Compass Therapeutics
CMPX

Overview Fund Activity

37 hedge funds and large institutions have $202M invested in Compass Therapeutics in 2021 Q4 according to their latest regulatory filings, with 37 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

Holders
37
Holders Change
+37
Holders Change %
–
% of All Funds
0.57%
Holding in Top 10
5
Holding in Top 10 Change
+5
Holding in Top 10 Change %
%
% of All Funds
0.08%
New
37
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
O
1
OrbiMed
New York
$68.6M
2
Fidelity Investments
2
Fidelity Investments
Massachusetts
$21.8M
3
RSCM
3
Rock Springs Capital Management
Maryland
$16.9M
4
FCMV
4
Foresite Capital Management V
California
$13.9M
5
CCM
5
Consonance Capital Management
New York
$11.2M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Shares
Change %
Citigroup
26
Citigroup
New York
$120K +$120K +37,834 New
Citadel Advisors
27
Citadel Advisors
Florida
$106K +$106K +33,573 New
Qube Research & Technologies (QRT)
28
Qube Research & Technologies (QRT)
United Kingdom
$92K +$92K +29,053 New
NCM
29
New Capital Management
Texas
$77K +$77K +24,243 New
JPMorgan Chase & Co
30
JPMorgan Chase & Co
New York
$75K +$75K +23,749 New
MFS
31
Mirabella Financial Services
United Kingdom
$60K +$60K +18,880 New
Morgan Stanley
32
Morgan Stanley
New York
$56K +$56K +17,473 New
MWM
33
Mascoma Wealth Management
New Hampshire
$50K +$50K +15,682 New
Millennium Management
34
Millennium Management
New York
$35K +$35K +11,157 New
DCM
35
Difesa Capital Management
New York
$33K +$33K +10,337 New
UBS Group
36
UBS Group
Switzerland
$23K +$23K +7,228 New
TRCT
37
Tower Research Capital (TRC)
New York
$10K +$10K +3,205 New
1
2